Strength or endurance: a trial that will look inside the muscle to explain the difference

Design

Two-arm, parallel-group exploratory randomised trial protocol with muscle biopsy and imaging endpoints

Population

69 patients — 23 rheumatoid arthritis, 23 osteoarthritis, 23 sarcopenia

Primary outcome

Isokinetic muscle strength (peak torque) after eight weeks

Effect

Not reported; the study is designed to produce effect size estimates for a confirmatory trial

Quadriceps weakness in knee osteoarthritis and in rheumatoid arthritis is treated with much the same prescription as age-related sarcopenia, largely because nobody has shown that the underlying muscle problem differs. The C4M study sets out to test that assumption.

Sixty-nine patients — 23 each with rheumatoid arthritis, osteoarthritis and sarcopenia — will be randomised to eight weeks of supervised endurance or strength exercise, two supervised sessions and one home session weekly. The primary outcome is isokinetic peak torque. What makes it interesting is the secondary set: 3D ultrasound of the vastus lateralis for muscle morphology, high-resolution respirometry on muscle biopsies for mitochondrial function, and serum inflammatory markers. The hypothesis is that intramuscular pathology differs by disease and predicts which kind of exercise helps.

The honest framing is that this is exploratory and small — 69 patients across three diseases and two arms is roughly 11 per cell. It is designed to generate effect size estimates for a future confirmatory trial, not to answer the question. Nothing about your exercise prescription should change; if anything, the useful reminder is that supervised, progressive, twice-weekly resistance work is the intervention with evidence behind it in all three groups today.

• Prescribe supervised progressive resistance exercise in knee osteoarthritis — that evidence already exists.
• Do not defer exercise in active rheumatoid arthritis; weakness compounds while you wait.
• Measure something repeatable — sit-to-stand count or grip — so progress is visible to the patient.
• Treat this trial as hypothesis-generating; it is not powered to compare disease groups.

Why it matters

It questions whether muscle weakness in inflammatory arthritis, osteoarthritis and ageing is the same problem.

Don't overread it

An exploratory trial of 69 patients across three diseases cannot establish which exercise suits which condition.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.